| Synonyms: | |
| Status: | Phase 2 |
| Entry Type: | Small molecule |
| Molecule Category: | UNKNOWN |
| UNII: | 5MB77ICE2Q |
| InChI Key | FUXVKZWTXQUGMW-FQEVSTJZSA-N |
|---|---|
| Smile | |
| InChI |
|
| Property Name | Value |
|---|---|
| Molecular Formula | C20H17N3O4 |
| Molecular Weight | 363.37 |
| AlogP | 1.66 |
| Hydrogen Bond Acceptor | 7.0 |
| Hydrogen Bond Donor | 2.0 |
| Number of Rotational Bond | 1.0 |
| Polar Surface Area | 107.44 |
| Molecular species | NEUTRAL |
| Aromatic Rings | 3.0 |
| Heavy Atoms | 27.0 |
| Mesh Heading | Maximum Phase | Mesh ID | Reference |
|---|---|---|---|
| Lung Neoplasms | 2 | D008175 | ClinicalTrials |
| Kidney Neoplasms | 2 | D007680 | ClinicalTrials |
| Esophageal Neoplasms | 2 | D004938 | ClinicalTrials |
| Ovarian Neoplasms | 2 | D010051 | ClinicalTrials |
| Lymphoma | 2 | D008223 | ClinicalTrials |
| Ovarian Neoplasms | 2 | D010051 | ClinicalTrials |
| Stomach Neoplasms | 2 | D013274 | ClinicalTrials |
| Peritoneal Neoplasms | 2 | D010534 | ClinicalTrials |
| Leukemia, Myeloid, Acute | 1 | D015470 | ClinicalTrials |
| Neoplasms | 1 | D009369 | ClinicalTrials |
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 1 | D054198 | ClinicalTrials |
| Resources | Reference |
|---|---|
| CAS NUMBER | 91421-43-1 |
| ChEBI | 80755 |
| ChEMBL | CHEMBL274070 |
| DrugBank | DB12515 |
| EPA CompTox | DTXSID10873202 |
| FDA SRS | 5MB77ICE2Q |
| KEGG | C16822 |
| PubChem | 72402 |
| SureChEMBL | SCHEMBL26578 |
| ZINC | ZINC000037866089 |